New research suggests that individuals who discontinue popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end traditional diet and exercise regimens.
Published data in a leading health publication shows that while obese people frequently drop about a fifth of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying these medications should be cognizant of the danger of fast rebound weight gain when the therapy concludes," stated expert Dr. Susan Jebb.
This pace of recovery means a return to pre-treatment weight in about 18 months.
Weighing Therapies
The analysis, which examined 37 of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with conventional dieting.
Scientists point out that individuals who shed pounds through lifestyle changes alone generally see a less rapid weight regain—approximately 100 grams monthly—once they finish.
Explaining the Fast Rebound
Doctors propose the mode of action of the jabs accounts for the heightened regain.
These medications mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its own natural GLP-1, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement results in appetite is unsuppressed, making excessive eating much more probable."
An Ongoing Disease?
Medical guidelines advise the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, due to the significant potential of weight regain, the therapy might need to be long-term.
This view is echoed by pharmaceutical companies, who note that the results "emphasize the long-term character of obesity," akin to managing conditions like diabetes.
Patient Experiences
People who have come off the medication explain a powerful return of appetite.
"It felt as if something flipping and I was suddenly ravenous," recalled a patient.
This difficulty is worsened if users have not developed sustainable dietary or behavioural changes during therapy.
Significant Adoption
Survey data suggest that a significant number of people in the UK have used these injections in the past year, with demand being substantial.
- Use is higher among women compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, experts emphasize that while the jabs are powerful agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on ongoing behavioural changes.
